New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin

Not Applicable

• Conditions: Metabolic Syndrome
• Interventions: Diagnostic Test: Serum blood

• Registration Number: NCT03469115
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

The purpose of this study is to find out if there is a connection between a higher level of peptide alpha defensin in blood serum with the metabolic profile of adolescents aged 13-17.

Detailed Description

Not available

Study Timeline

• Status Verified: 2018-03
• Study Start: 2018-03
• Study First Submitted: 2018-03-12
• Study First Submitted QC: 2018-03-12
• Last Update Submitted: 2018-03-12
• Study First Posted: 2018-03-19
• Last Update Posted: 2018-03-19
• Primary Completion: 2019-09
• Study Completion: 2019-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Youths with metabolic syndrome (BMI above 95%)
• Youths with BMI below 3%

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
BMI above 95%	Serum blood	Serum blood will be taken from obese youths with suspected metabolic syndrome
BMI below 3%	Serum blood	Serum blood will be taken from slim youths

Primary Outcome Measures

Name	Time	Method
Alpha defensin level	2 hours	Alpha defensin level above 12ng/microliter

Trial Locations

Locations (1)

Hille Yaffe Medical Center; 🇮🇱 Hadera, Israel